Joseph Sabat1, Diane Bock1, Chiu-Hsieh Hsu2, Tze-Woei Tan1, Craig Weinkauf1, Theodore Trouard3, Gloria Guzman Perez-Carrillo4, Wei Zhou5. 1. Division of Vascular Surgery, University of Arizona College of Medicine, Tucson, Ariz. 2. Division of Epidemiology and Biostatistics, University of Arizona College of Medicine, Tucson, Ariz. 3. College of Engineering, University of Arizona, Tucson, Ariz. 4. Division of Radiology, University of Arizona, Tucson, Ariz. 5. Division of Vascular Surgery, University of Arizona College of Medicine, Tucson, Ariz. Electronic address: zhouw@surgery.arizona.edu.
Abstract
BACKGROUND: Microembolization after carotid artery stenting (CAS) and carotid endarterectomy (CEA) has been documented and may confer risk for neurocognitive impairment. Patients undergoing stenting are known to be at higher risk for microembolization. In this prospective cohort study, we compare the microembolization rates for patients undergoing CAS and CEA and perioperative characteristics that may be associated with microembolization. METHODS: Patients undergoing CAS and CEA were prospectively recruited under local institutional review board approval from an academic medical center. All patients also received 3T brain magnetic resonance imaging with a diffusion-weighted imaging sequence preoperatively and within 24 hours postoperatively to identify procedure-related new embolic lesions. Preoperative, postoperative, procedural factors, and plaque characteristics were collected. Factors were tested for statistical significance with logistic regression. RESULTS: A total of 202 patients were enrolled in the study. There were 107 patients who underwent CAS and 95 underwent CEA. Patients undergoing CAS were more likely to have microemboli than patients undergoing CEA (78% vs 27%; P < .0001). For patients undergoing CAS, patency of the external carotid artery (odds ratio [OR], 11.4; 95% confidence interval [CI], 1.11-117.6; P = .04), lesion calcification (OR, 5.68; 95% CI, 1.12-28.79; P = .04), and lesion length (OR, 0.29; 95% CI, 0.08-1.01; P = .05) were all found to be independent risk factors for perioperative embolization. These factors did not confer increased risk to patients undergoing CEA. CONCLUSIONS: Patients undergoing CAS are at higher risk for perioperative embolization. The risk for perioperative embolization is related to the length of the lesion and calcification. Identifying the preoperative risk factors may help to guide patient selection and, thereby, reduce embolization-related neurocognitive impairment.
BACKGROUND: Microembolization after carotid artery stenting (CAS) and carotid endarterectomy (CEA) has been documented and may confer risk for neurocognitive impairment. Patients undergoing stenting are known to be at higher risk for microembolization. In this prospective cohort study, we compare the microembolization rates for patients undergoing CAS and CEA and perioperative characteristics that may be associated with microembolization. METHODS: Patients undergoing CAS and CEA were prospectively recruited under local institutional review board approval from an academic medical center. All patients also received 3T brain magnetic resonance imaging with a diffusion-weighted imaging sequence preoperatively and within 24 hours postoperatively to identify procedure-related new embolic lesions. Preoperative, postoperative, procedural factors, and plaque characteristics were collected. Factors were tested for statistical significance with logistic regression. RESULTS: A total of 202 patients were enrolled in the study. There were 107 patients who underwent CAS and 95 underwent CEA. Patients undergoing CAS were more likely to have microemboli than patients undergoing CEA (78% vs 27%; P < .0001). For patients undergoing CAS, patency of the external carotid artery (odds ratio [OR], 11.4; 95% confidence interval [CI], 1.11-117.6; P = .04), lesion calcification (OR, 5.68; 95% CI, 1.12-28.79; P = .04), and lesion length (OR, 0.29; 95% CI, 0.08-1.01; P = .05) were all found to be independent risk factors for perioperative embolization. These factors did not confer increased risk to patients undergoing CEA. CONCLUSIONS: Patients undergoing CAS are at higher risk for perioperative embolization. The risk for perioperative embolization is related to the length of the lesion and calcification. Identifying the preoperative risk factors may help to guide patient selection and, thereby, reduce embolization-related neurocognitive impairment.
Authors: Jerry J Kim; Samuel Schwartz; Johnny Wen; Christian deVirgilio; Abeline Lobue; Irwin Walot; Matthew Koopmann; Carlos Donayre; Rodney A White Journal: Am Surg Date: 2015-10 Impact factor: 0.688
Authors: Frank D Hammer; Valerie Lacroix; Thierry Duprez; Cecile Grandin; Robert Verhelst; Andre Peeters; Guy Cosnard Journal: J Vasc Surg Date: 2005-11 Impact factor: 4.268
Authors: J Golledge; R Gibbs; C Irving; G Clayton; D Bond; R M Greenhalgh; P Lamont; A H Davies Journal: J Vasc Surg Date: 2001-12 Impact factor: 4.268
Authors: G G Ferguson; M Eliasziw; H W Barr; G P Clagett; R W Barnes; M C Wallace; D W Taylor; R B Haynes; J W Finan; V C Hachinski; H J Barnett Journal: Stroke Date: 1999-09 Impact factor: 7.914
Authors: M Silvestrini; I Paolino; F Vernieri; C Pedone; R Baruffaldi; B Gobbi; C Cagnetti; L Provinciali; M Bartolini Journal: Neurology Date: 2009-03-24 Impact factor: 9.910